Skip to content
2000
Volume 21, Issue 2
  • ISSN: 1573-398X
  • E-ISSN: 1875-6387

Abstract

Background

Bronchiectases are structural alterations characterized by the dilation of bronchial walls due to inflammation, resulting in a loss of elasticity and muscle function. They are more common in adults than children and have various etiologies (such as chronic infections, particularly in developing countries, or immunodeficiencies in industrialized nations), with up to 40% being idiopathic.

Case Presentation

We reported the case of a nine-year-old child who, following two lower respiratory tract infections (a severe H1N1 influenza pneumonia and a milder episode caused by M. ), developed bronchiectasis without underlying predisposing conditions.

Discussion

Bronchiectasis is a morphological alteration of the bronchi, which can develop subsequently to lung infections and may remain clinically silent even for a long time. The most common associated symptoms include productive cough, persistent rales, therapy-resistant “asthma,” and recurrent lung infections. High-Resolution CT (HRCT) scans are the gold standard for their diagnosis, while their management requires a comprehensive approach, including pharmacological and psychosocial measures. It is always advisable to investigate the underlying etiology to eventually establish a causal treatment.

Conclusion

This study aims to emphasize that not only bacteria but also viral infections and their associated inflammatory impact on lung tissue can contribute to the development of bronchiectasis. This study aims to implement current knowledge regarding non-cystic fibrosis-related bronchiectasis and to underscore the significance of post-acute instrumental reassessment in lower respiratory tract infections, especially when severe.

Loading

Article metrics loading...

/content/journals/crmr/10.2174/011573398X292518240508070919
2024-05-16
2025-01-22
Loading full text...

Full text loading...

References

  1. ChalmersJ.D. ChotirmallS.H. Bronchiectasis: New therapies and new perspectives.Lancet Respir. Med.20186971572610.1016/S2213‑2600(18)30053‑529478908
    [Google Scholar]
  2. EberE. MidullaF. ERS Handbook of Paediatric Respiratory Medicine. II edition.European Respiratory Society202110.1183/9781849841313.eph01
    [Google Scholar]
  3. GaffarS. LeeW.W. HarringtonJ.W. Bronchiectasis.Pediatr. Rev.202142210310510.1542/pir.2020‑011033526578
    [Google Scholar]
  4. ChalmersJ.D. ChangA.B. ChotirmallS.H. DharR. McShaneP.J. Bronchiectasis.Nat. Rev. Dis. Primers2018414510.1038/s41572‑018‑0042‑330442957
    [Google Scholar]
  5. GoyalV. GrimwoodK. MarchantJ. MastersI.B. ChangA.B. Pediatric bronchiectasis: No longer an orphan disease.Pediatr. Pulmonol.201651545046910.1002/ppul.2338026840008
    [Google Scholar]
  6. BushA. FlotoR.A. Pathophysiology, causes and genetics of paediatric and adult bronchiectasis.Respirology201924111053106210.1111/resp.1350930801930
    [Google Scholar]
  7. ChangA.B. BushA. GrimwoodK. Bronchiectasis in children: Diagnosis and treatment.Lancet20183921015086687910.1016/S0140‑6736(18)31554‑X30215382
    [Google Scholar]
  8. PolverinoE. GoeminneP.C. McDonnellM.J. AlibertiS. MarshallS.E. LoebingerM.R. MurrisM. CantónR. TorresA. DimakouK. De SoyzaA. HillA.T. HaworthC.S. VendrellM. RingshausenF.C. SuboticD. WilsonR. VilaróJ. StallbergB. WelteT. RohdeG. BlasiF. ElbornS. AlmagroM. TimothyA. RuddyT. ToniaT. RigauD. ChalmersJ.D. European respiratory society guidelines for the management of adult bronchiectasis.Eur. Respir. J.2017503170062910.1183/13993003.00629‑201728889110
    [Google Scholar]
  9. SchäferJ. GrieseM. ChandrasekaranR. ChotirmallS.H. HartlD. Pathogenesis, imaging and clinical characteristics of CF and non-CF bronchiectasis.BMC Pulm. Med.20181817910.1186/s12890‑018‑0630‑829788954
    [Google Scholar]
  10. GuptaA.K. LodhaR. KabraS.K. Non cystic fibrosis bronchiectasis.Indian J. Pediatr.2015821093894410.1007/s12098‑015‑1866‑426307756
    [Google Scholar]
  11. PasteurM.C. BiltonD. HillA.T. British Thoracic Society Bronchiectasis non-CF Guideline Group British thoracic society guideline for non-CFbronchiectasis.Thorax201065Suppl. 1i1i5810.1136/thx.2010.13611920627931
    [Google Scholar]
  12. ChangA.B. FortescueR. GrimwoodK. AlexopoulouE. BellL. BoydJ. BushA. ChalmersJ.D. HillA.T. KaradagB. MidullaF. McCallumG.B. PowellZ. SnijdersD. SongW.J. ToniaT. WilsonC. ZacharasiewiczA. KantarA. European respiratory society guidelines for the management of children and adolescents with bronchiectasis.Eur. Respir. J.2021582200299010.1183/13993003.02990‑202033542057
    [Google Scholar]
  13. WangD. FuW. DaiJ. Meta-analysis of macrolide maintenance therapy for prevention of disease exacerbations in patients with noncystic fibrosis bronchiectasis.Medicine20199817e1528510.1097/MD.000000000001528531027086
    [Google Scholar]
  14. WuJ. ChangA.B. WurzelD.F. Contemporary management of bronchiectasis in children.Expert Rev. Respir. Med.2019131096997910.1080/17476348.2019.165540031408389
    [Google Scholar]
  15. ChangA.B. KantarA. ReddingG.J. HillA.T. Is bronchiectasis a reversible disorder?Arch. Bronconeumol.202359419920010.1016/j.arbres.2022.11.00736464516
    [Google Scholar]
/content/journals/crmr/10.2174/011573398X292518240508070919
Loading
/content/journals/crmr/10.2174/011573398X292518240508070919
Loading

Data & Media loading...


  • Article Type:
    Case Report
Keyword(s): Bronchiectasis; cough; HRCT; influenza; mycoplasma pneumoniae; pneumonia
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test